Comparing Etest and Broth Microdilution for Antifungal Susceptibility Testing of the Most-Relevant Pathogenic Molds

被引:46
作者
Lamoth, Frederic [1 ,2 ,3 ,4 ]
Alexander, Barbara D. [1 ,2 ]
机构
[1] Duke Univ, Med Ctr, Dept Med, Div Infect Dis & Int Hlth, Durham, NC 27710 USA
[2] Duke Univ, Med Ctr, Dept Pathol, Clin Microbiol Lab, Durham, NC 27710 USA
[3] Univ Lausanne Hosp, Dept Med, Infect Dis Serv, Lausanne, Switzerland
[4] Univ Lausanne Hosp, Inst Microbiol, Lausanne, Switzerland
基金
瑞士国家科学基金会;
关键词
SURVEILLANCE NETWORK TRANSNET; INVASIVE FUNGAL-INFECTIONS; FILAMENTOUS FUNGI; ASPERGILLUS SPP; AMPHOTERICIN-B; TRANSPLANT RECIPIENTS; ITRACONAZOLE MICS; AZOLE RESISTANCE; POSACONAZOLE; VORICONAZOLE;
D O I
10.1128/JCM.00925-15
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Invasive mold infections are life-threatening diseases for which appropriate antifungal therapy is crucial. Their epidemiology is evolving, with the emergence of triazole-resistant Aspergillus spp. and multidrug-resistant non-Aspergillus molds. Despite the lack of interpretive criteria, antifungal susceptibility testing of molds may be useful in guiding antifungal therapy. The standard broth microdilution method (BMD) is demanding and requires expertise. We assessed the performance of a commercialized gradient diffusion method (Etest method) as an alternative to BMD. The MICs or minimal effective concentrations (MECs) of amphotericin B, voriconazole, posaconazole, caspofungin, and micafungin were assessed for 290 clinical isolates of the most representative pathogenic molds (154 Aspergillus and 136 non-Aspergillus isolates) with the BMD and Etest methods. Essential agreements (EAs) within +/- 2 dilutions of >= 90% between the two methods were considered acceptable. EAs for amphotericin B and voriconazole were >90% for most potentially susceptible species. For posaconazole, the correlation was acceptable for Mucoromycotina but Etest MIC values were consistently lower for Aspergillus spp. (EAs of <90%). Excellent EAs were found for echinocandins with highly susceptible (MECs of <0.015 mu g/ml) or intrinsically resistant (MECs of >16 mu g/ml) strains. However, MEC determinations lacked consistency between methods for strains exhibiting mid-range MECs for echinocandins. We concluded that the Etest method is an appropriate alternative to BMD for antifungal susceptibility testing of molds under specific circumstances, including testing with amphotericin B or triazoles for non-Aspergillus molds (Mucoromycotina and Fusarium spp.). Additional study of molecularly characterized triazole-resistant Aspergillus isolates is required to confirm the ability of the Etest method to detect voriconazole and posaconazole resistance among Aspergillus spp.
引用
收藏
页码:3176 / 3181
页数:6
相关论文
共 25 条
[1]   Comparison of Assessment of Oxygen Consumption, Etest, and CLSI M38-A2 Broth Microdilution Methods for Evaluation of the Susceptibility of Aspergillus fumigatus to Posaconazole [J].
Araujo, Ricardo ;
Espinel-Ingroff, Ana .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (11) :4921-4923
[2]   Comparative in vitro activities of posaconazole, voriconazole, itraconazole, and amphotericin B against Aspergillus and Rhizopus, and synergy testing for Rhizopus [J].
Arikan, Sevtap ;
Sancak, Banu ;
Alp, Sehnaz ;
Hascelik, Gulsen ;
Mcnicholas, Paul .
MEDICAL MYCOLOGY, 2008, 46 (06) :567-573
[3]  
Clinical and Laboratory Standards Institute, 2008, REF METH BROTH DIL A
[4]   Scopulariopsis brevicaulis, a fungal pathogen resistant to broad-spectrum antifungal agents [J].
Cuenca-Estrella, M ;
Gomez-Lopez, A ;
Mellado, E ;
Buitrago, MJ ;
Monzón, A ;
Rodriguez-Tudela, JL .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (07) :2339-2341
[5]   In vitro antifungal susceptibility of filamentous fungi causing rare infections: synergy testing of amphotericin B, posaconazole and anidulafungin in pairs [J].
Drogari-Apiranthitou, Maria ;
Mantopoulou, Foteini-Despina ;
Skiada, Anna ;
Kanioura, Lambrini ;
Grammatikou, Maria ;
Vrioni, Georgia ;
Mitroussia-Ziouva, Aggeliki ;
Tsakris, Athanassios ;
Petrikkos, George .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2012, 67 (08) :1937-1940
[6]   Is Azole Resistance in Aspergillus fumigatus a Problem in Spain? [J].
Escribano, Pilar ;
Pelaez, Teresa ;
Munoz, Patricia ;
Bouza, Emilio ;
Guinea, Jesus .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (06) :2815-2820
[7]   Comparison of three commercial assays and a modified disk diffusion assay with two broth microdilution reference assays for testing Zygomycetes, Aspergillus spp., Candida spp., and Cryptococcus neoformans with posaconazole and Amphotericin B [J].
Espinel-Ingroff, A. .
JOURNAL OF CLINICAL MICROBIOLOGY, 2006, 44 (10) :3616-3622
[8]   Evaluation of broth microdilution testing parameters and agar diffusion Etest procedure for testing susceptibilities of Aspergillus spp. to caspofungin acetate (MK-0991) [J].
Espinel-Ingroff, A .
JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (01) :403-409
[9]   E-test method for testing susceptibilities of Aspergillus spp. to the new triazoles voriconazole and posaconazole and to established antifungal agents:: Comparison with NCCLS broth microdilution method [J].
Espinel-Ingroff, A ;
Rezusta, A .
JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (06) :2101-2107
[10]   Comparison of the E-test with the NCCLS M38-P method for antifungal susceptibility testing of common and emerging pathogenic filamentous fungi [J].
Espinel-Ingroff, A .
JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (04) :1360-1367